Intrathecal Hydromorphone for Cesarean Section
Completed · Phase 4
Conditions studied: Pain
In brief
Introduction: Cesarean section (C/S) is usually performed under spinal with preservative free morphine for pain relief, but the investigators have a severe shortage of this formulation of morphine. Hydromorphone is a narcotic which acts peripherally and centrally to decrease pain. It has been used in spinals for postoperative pain relief and in pain pumps for relief of chronic pain. No randomized controlled studies have evaluated intrathecal (IT) hydromorphone for post C/S pain. Methods: This is a randomized double-blind controlled trial utilizing the up-down sequential allocation method1,2 to find the best dose of IT hydromorphone that provides pain relief following C/S. Patients will be given a morphine PCA pump for additional pain relief. Our first patient will receive 200 mcg of IT hydromorphone. Pain, nausea, and itching will be evaluated at 4, 8, 12 and 24 hours following the C/S via numeric rating scales; vomiting and morphine use per hour will be recorded. Success will be a median morphine usage of less than or equal to 1mg/hour in the following 16 hours. If a success, the next patient will be given 10 mcg less IT hydromorphone; if a failure, she will receive 10 mcg more. The study will end after 5 successes. Objective: The primary objective is to find the optimal dose of IT hydromorphone for pain relief following C/S. The secondary objectives are to define the incidence and severity of hydromorphone's side effects and determine the duration of analgesia.
Key facts
- Study ID
- NCT02067520
- Run by
- Thomas Jefferson University
- People needed
- 54
- Starts
- 2014-01-01
- Expected to finish
- 2015-06-01
- Last updated by the study team
- 2016-01-08
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Females undergoing a primary or repeat elective, scheduled C/S who are not yet in labor will be approached for inclusion in the study
You may not qualify if…
- Patient refusal,
- Age less than 18 years
- Onset of labor
- Current opioid abuse
- Use of methadone maintenance for previous opioid abuse
- Allergy to hydromorphone
- Contraindication to spinal anesthesia
- Inability to obtain a spinal anesthetic
- Language other than English or if unable to understand use of a PCA pump will be excluded.
Where it is running
- Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.